Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL316176 | 1.00 | ABL1 (0.31) | ABL1PIK3CACYP11B2 | |
| SCHEMBL2411942 | 0.88 | PIM2 (0.38) | ABL1PIK3CA | |
| SCHEMBL2411945 | 0.88 | PIM2 (0.38) | ABL1PIK3CA | |
| SCHEMBL314917 | 0.87 | CYP2A6 (0.38) | ABL1CYP11B2 | |
| SCHEMBL3395978 | 0.87 | CYP2A6 (0.38) | ABL1CYP11B2 | |
| SCHEMBL314162 | 0.86 | DGAT2 (0.32) | — | |
| SCHEMBL314163 | 0.86 | DGAT2 (0.32) | — | |
| SCHEMBL316064 | 0.85 | CHRNB1 (0.34) | ABL1CYP11B2 | |
| SCHEMBL316063 | 0.85 | CHRNB1 (0.34) | ABL1CYP11B2 | |
| SCHEMBL315649 | 0.85 | CHRNB1 (0.37) | ABL1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8093394-B2 | Derivatives of 5-thioxylopyranose and use of same for treatment | LABORATOIRES FOURNIER S.A. (FR) | 2012-01-10 | — | — | US | disclosed |
| US-20090182013-A1 | Derivatives of 5-Thioxylopyranose and Use of Same for Treatment | LABORATOIRES FOURNIER S.A. (FR) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182013-A1 | Derivatives of 5-Thioxylopyranose and Use of Same for Treatment | TPMT, PNPO, PPOX | ABL1 1574/4885PIK3CA 1737/4885CYP11B2 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.